These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 36034801)
21. Integrative Analysis of Pyroptosis-Related Prognostic Signature and Immunological Infiltration in Lung Squamous Cell Carcinoma. Luo P; Jiang Y; Ding S; Jiang S; Tang R; Tang Z Biomed Res Int; 2022; 2022():4944758. PubMed ID: 35692583 [TBL] [Abstract][Full Text] [Related]
22. Development and validation of a pyroptosis-related prognostic signature associated with osteosarcoma metastasis and immune infiltration. Gong Z; Wan Y; Han E; Zhou X; Huang J; Yu H; Shi Y; Lian K Medicine (Baltimore); 2024 Apr; 103(14):e37642. PubMed ID: 38579086 [TBL] [Abstract][Full Text] [Related]
23. Identification of a pyroptosis related gene signature for predicting prognosis and estimating tumor immune microenvironment in bladder cancer. Zhao J; Wu C; Wang Y; Li M; Jiang Y; Luo Y Transl Cancer Res; 2022 Jul; 11(7):1865-1879. PubMed ID: 35966309 [TBL] [Abstract][Full Text] [Related]
24. Identification of an Immune-Related Gene Signature Based on Immunogenomic Landscape Analysis to Predict the Prognosis of Adult Acute Myeloid Leukemia Patients. Zhu R; Tao H; Lin W; Tang L; Hu Y Front Oncol; 2020; 10():574939. PubMed ID: 33330048 [TBL] [Abstract][Full Text] [Related]
25. Identification of a Pyroptosis-Related Gene Signature for Predicting the Immune Status and Prognosis in Lung Adenocarcinoma. Gong Z; Li Q; Yang J; Zhang P; Sun W; Ren Q; Tang J; Wang W; Gong H; Li J Front Bioeng Biotechnol; 2022; 10():852734. PubMed ID: 35646872 [No Abstract] [Full Text] [Related]
26. The pyroptosis-related gene signature predicts prognosis and indicates the immune microenvironment status of chronic lymphocytic leukemia. Sha Y; Jiang R; Miao Y; Qin S; Wu W; Xia Y; Wang L; Fan L; Jin H; Xu W; Li J; Zhu H Front Immunol; 2022; 13():939978. PubMed ID: 36177050 [TBL] [Abstract][Full Text] [Related]
27. Identification and Validation of a Novel Pyroptosis-Related Gene Signature for Prognosis Prediction in Soft Tissue Sarcoma. Qi L; Xu R; Wan L; Ren X; Zhang W; Zhang K; Tu C; Li Z Front Genet; 2021; 12():773373. PubMed ID: 34925457 [TBL] [Abstract][Full Text] [Related]
28. A novel identified pyroptosis-related prognostic signature of colorectal cancer. Zheng C; Tan Z Math Biosci Eng; 2021 Oct; 18(6):8783-8796. PubMed ID: 34814322 [TBL] [Abstract][Full Text] [Related]
29. Development and validation of a pyroptosis-related genes signature for risk stratification in gliomas. Sun P; Wang X; Zhong J; Yu D; Xuan H; Xu T; Song D; Yang C; Wang P; Liu Y; Meng X; Cai J Front Genet; 2023; 14():1087563. PubMed ID: 36861130 [No Abstract] [Full Text] [Related]
30. Development of a Prognostic Model of Glioma Based on Pyroptosis-Related Genes. Niu X; Cheng R; Wang Y; Chen J; Wang C; Ji H World Neurosurg; 2022 Feb; 158():e929-e945. PubMed ID: 34861452 [TBL] [Abstract][Full Text] [Related]
31. Pyroptosis-Related Gene to Construct Prognostic Signature and Explore Immune Microenvironment and Immunotherapy Biomarkers in Bladder Cancer. Zhang X; Liang H; Tang Q; Chen H; Guo F Front Genet; 2022; 13():801665. PubMed ID: 35846123 [TBL] [Abstract][Full Text] [Related]
32. Identification of a pyroptosis-related prognostic signature in breast cancer. Chen H; Luo H; Wang J; Li J; Jiang Y BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644 [TBL] [Abstract][Full Text] [Related]
33. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
34. A novel signature based on pyroptosis-related genes for predicting prognosis and treatment response in prostate cancer patients. Xiao X; Li J; Wan S; Wu M; Li Z; Tian J; Mi J Front Genet; 2022; 13():1006151. PubMed ID: 36386841 [No Abstract] [Full Text] [Related]
35. The pyroptosis-related signature predicts prognosis and influences the tumor immune microenvironment in dedifferentiated liposarcoma. Chen W; Cheng J; Cai Y; Wang P; Jin J Open Med (Wars); 2024; 19(1):20230886. PubMed ID: 38221934 [TBL] [Abstract][Full Text] [Related]
36. A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer. Ping L; Zhang K; Ou X; Qiu X; Xiao X Front Cell Dev Biol; 2021; 9():727183. PubMed ID: 34616734 [No Abstract] [Full Text] [Related]
37. Identification and verification of the pyroptosis-related prognostic signature and its associated regulatory axis in bladder cancer. Tu Y; Ding X; Mao Z Front Cell Dev Biol; 2022; 10():912008. PubMed ID: 36120583 [No Abstract] [Full Text] [Related]
38. Pyroptosis regulators exert crucial functions in prognosis, progression and immune microenvironment of pancreatic adenocarcinoma: a bioinformatic and in vitro research. Bai Z; Xu F; Feng X; Wu Y; Lv J; Shi Y; Pei H Bioengineered; 2022 Jan; 13(1):1717-1735. PubMed ID: 35000541 [TBL] [Abstract][Full Text] [Related]
39. Pyroptosis-Related Risk Signature Exhibits Distinct Prognostic, Immune, and Therapeutic Landscapes in Hepatocellular Carcinoma. Zhao Y; Song Q; Xu F; Zhou Y; Zuo X; Zhang Z Front Genet; 2022; 13():823443. PubMed ID: 35368686 [No Abstract] [Full Text] [Related]
40. Molecular Characteristics, Clinical Implication, and Cancer Immunity Interactions of Pyroptosis-Related Genes in Breast Cancer. Xu D; Ji Z; Qiang L Front Med (Lausanne); 2021; 8():702638. PubMed ID: 34589498 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]